Li, Muhan
Liu, Minying
Cui, Qianyu
Zeng, Min
Li, Shu
Zhang, Liyong
Peng, Yuming http://orcid.org/0000-0002-2630-2467
Funding for this research was provided by:
Key Technologies Research and Development Program (2018YFC2001901)
Article History
Received: 23 November 2022
Accepted: 8 September 2023
First Online: 25 September 2023
Declarations
:
: The study protocol (V.1.2, 18 January 2022) has been approved by the Medical Ethics Committee of Beijing Tiantan Hospital, Capital Medicine University (No. KY2022-002–02). Patients will be informed of the study objectives, risks, and benefits. Written informed consent will be obtained from patients, their next of kin, or legal representatives. No identifying images or other personal or clinical details of participants are presented here or will be presented in reports of the trial results. Informed consent materials are available, on request, from the corresponding author. The participants will be asked if they agree to use their data should they choose to withdraw from the trial. Participants will also be asked for permission for the research team to share relevant data with people from the Universities taking part in the research or from regulatory authorities, where relevant. This trial does not involve collecting biological specimens for storage.
: The findings of the study will be disseminated in a peer-reviewed journal and at a scientific conference.
: The authors declare that they have no competing interests.